FLT3 and acute myeloid leukemia: FLT3 internal tandem duplications (ITDs) of the juxtamembrane domain occurs in around 25% of AML patients [8], and point mutations in the activation loop of the tyrosine kinase domain (TKD) occurs in about 5–10% of AML patients [8].